References
- Ganong WF. Review of Medical Physiology, 14th edn. Los Altos: Lange Medical Publications, 1989:374–9
- Kerr JB. Atlas of Functional Histology. London: Mosby, 1998:315–18
- Katzung BG. Basic and Clinical Pharmacology, 6th edn. Los Altos: Lange Medical Publications, 1995: 609–10
- Adeghate E. Effect of oral contraceptive steroid hormones on metabolic parameters of strepto zo to cm-induced diabetic rat. Contraception 2000;62:327–9
- Luotola H, Pyorala T, Loikkanen M. Effects of natural oestrogen/progestogen substitution therapy on carbohydrate and lipid metabolism in post-menopausalwomen. Maturitas 1986;8:245–53
- Andersson B, Mattsson LA, Hahn L, et al. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dep endent diabetes mellitus. J Clin Endocrinol Metab 1997;82:638–43
- Troisi RJ, Cowie CC, Harris MI. Oral contracep-tive use and glucose metabolism in a national sample of women in the United States. Am J Obstet Gynecol 2000;183:389–95
- Brussard HE, Gevers-Leuven JA, Frolich M, et al. Short-term replacement therapy improves insulin resistance, lipid and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 1997;40:843–9
- Brussaard HE, Gevers Leuven JA, Kluft C, et al. Effect of17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus. Arteriosder Thromb Vasc Biol1997; 17:324–30
- Nadal A, Rovira JM, Laribi 0, et al. Rapid insulinotropic effect of 17-beta-estradiol via a plasma membrane receptor. FASEB J 1998;12: 1341–8
- Herbert V, Lau KS, Gottlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol 1965;25:1375–8
- Adeghate E. Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced dia-betes in rats. II. Endocrine and metabolic functions. Tissue Cell 1999;31:73–83
- Sp ellacy WN, Buhi WC, Birk SA, Buggie J. Blood glucose and plasma insulin studies during three months' use of a low-estrogen type oral contracep-tive. Fertil Steril 1981;36:68–70
- Radberg T, Gustafion A, Skryten A, Karlsson K. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progesto-gen and combined estrogen/progestogen contra-ception. Horm Metab Res 1982;14:61–5
- Skouby SO, Molsted-Pedersen L, Kuhl C. Low dosage oral contraception in women with previous gestational diabetes. Obstet Gynecol 1982;59:325–8
- Rubio Lotvin B. The desogestrel-ethinyl estradiol combination and overweight: current data. Ginecol Obstet Mex 1995;63:483–6
- Muck BR, Hommel G. Effect of oral contracep-tives on plasma insulin and blood glucose levels after long term use. Arch Gynakol1976 ;221 :61–72
- Skouby SO, Kuhl C, Molsted-Pedersen L, et al. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes. Am J Obstet Gynecol 1985;153:495–500
- Petersen KR, Skouby SO, Vedel P, Haaber AB. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipo-protein metabolism. Diabetes Care 1995;18:800–6
- Goodman MN, Hazelwood RL. Short-term effects of oestradiol benzoate in normal, hypo-physectomized and alloxan-diabetic male rats. J Endocrinol 1974;62:439–49